87 related articles for article (PubMed ID: 17111783)
21. Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study.
Harris HE; Costella A; Amirthalingam G; Alexander G; Ramsay ME; Andrews N; ;
Epidemiol Infect; 2012 Oct; 140(10):1830-7. PubMed ID: 22124380
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.
Pho MT; Jensen DM; Meltzer DO; Kim AY; Linas BP
J Viral Hepat; 2015 Aug; 22(8):630-8. PubMed ID: 26135026
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing Countries.
Aziz S
J Clin Transl Hepatol; 2014 Dec; 2(4):247-52. PubMed ID: 26356647
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection.
Nodarse-Cuni H; Bravo O; Cañete R; Vázquez-Blomquist D; Quintana D; Aguilera-Barreto A; Guillen-Nieto G; Arteaga A; Morales I
J Interferon Cytokine Res; 2024 Jun; 44(6):271-280. PubMed ID: 38597374
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-α 2b therapy.
Keles S; Jabara HH; Reisli I; McDonald DR; Barlan I; Hanna-Wakim R; Dbaibo G; Lefranc G; Al-Herz W; Geha RS; Chatila TA
J Allergy Clin Immunol; 2014 Jun; 133(6):1753-5.e3. PubMed ID: 24767873
[No Abstract] [Full Text] [Related]
26. Random effect model for identifying related factors to virological response in HCV patients.
Zayeri F; Chaibakhsh S; Pourhoseingholi A; Baghban AA; Alavian SM
Gastroenterol Hepatol Bed Bench; 2013; 6(Suppl 1):S65-9. PubMed ID: 24834290
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic HCV infection in special populations.
Hoefs J; Aulakh VS
Int J Med Sci; 2006; 3(2):69-74. PubMed ID: 16614746
[TBL] [Abstract][Full Text] [Related]
28. Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection.
Panfilio S; D'Urso P; Annechini G; D'Elia GM; De Angelis F; Stefanizzi C; Pulsoni A
Leuk Res Rep; 2013; 2(1):39-40. PubMed ID: 24371776
[TBL] [Abstract][Full Text] [Related]
29. The faster the better?
Carulli N
Intern Emerg Med; 2006; 1(2):91-3. PubMed ID: 17111779
[No Abstract] [Full Text] [Related]
30. Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL; Yu ML; Dai CY; Chang WY
Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
[TBL] [Abstract][Full Text] [Related]
31. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
[TBL] [Abstract][Full Text] [Related]
32. Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.
Benetti G; Borzio M; Ramella G; Bellati G; Fargion S; Colombo A; Croce G; Iamoletti C; Balzola F; Rizzetto M;
Intern Emerg Med; 2006; 1(2):113-8. PubMed ID: 17111783
[TBL] [Abstract][Full Text] [Related]
33. Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
Tomimatsu M; Aizawa Y; Chuganji Y; Ishizuka H; Fujita Y; Aizawa R; Abe H; Matsuda T; Itou Y; Nakanishi H; Ushiyama H; Higuchi T; Fujimoto T; Endou H; Iga D; Ohta K; Kuroda H
J Gastroenterol Hepatol; 2006 Jul; 21(7):1177-83. PubMed ID: 16824072
[TBL] [Abstract][Full Text] [Related]
34. High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.
Wartelle-Bladou C; Arpurt JP; Renou C; Pariente A; Pillon D; Nalet B; Picon M; Glibert A; Chousterman M; Grasset D; Morin T; Bernard P; Fischer D; Ramdani M; Lagier E; Rotily M;
Gastroenterol Clin Biol; 2006 Apr; 30(4):525-32. PubMed ID: 16733374
[TBL] [Abstract][Full Text] [Related]
35. Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.
Bjøro K; Bell H; Myrvang B; Skaug K; Raknerud N; Sandvei P; Størseth S; Ritland S; Lund-Tønnesen S; Bucher A; Hellum KB
Scand J Gastroenterol; 2002 Mar; 37(3):344-9. PubMed ID: 11916198
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C.
Pérez R; Jiménez M; Crespo J; Diago M; Enríquez J; Vaquero P; Solá R; Olcoz JL; Romero M; Salmerón J; Blanco MI; Oña M; Melón S; Rodrigo L;
J Viral Hepat; 2003 Nov; 10(6):437-45. PubMed ID: 14633177
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
